[COMPREHENSIVE GUIDELINES AND INDICATIONS FOR DIGITAL MONITORING OF PATIENTS AT HIGH-RISK FOR MELANOMA: A POSITION PAPER BY THE ISRAELI ASSOCIATION FOR DERMATOLOGY].


Journal

Harefuah
ISSN: 0017-7768
Titre abrégé: Harefuah
Pays: Israel
ID NLM: 0034351

Informations de publication

Date de publication:
Apr 2024
Historique:
medline: 15 4 2024
pubmed: 15 4 2024
entrez: 15 4 2024
Statut: ppublish

Résumé

Early detection may lead to reduced morbidity and mortality from melanoma. This study aims to establish guidelines for selecting patients suitable for digital monitoring of skin lesions. A literature review was conducted, followed by consensus among experts appointed by the Israeli Dermatology Association. Two effective methods for early melanoma diagnosis were identified: Total-body photography (TBP) and digital dermoscopy. TBP involves capturing clinical images of the entire skin area for long-term monitoring (6-12 months). Digital dermoscopy focuses on close-up images of distinct lesions for short-term monitoring (3-4 months). Various risk factors for melanoma were identified, including genetic and familial factors, as well as demographic and phenotypic characteristics. Based on these risk factors and feasibility of clinical follow-up, a comprehensive list of indications for TBP was developed, categorized into three groups based on the expected level of benefit. Digital dermoscopy surveillance is recommended for patients with flat or slightly raised skin lesions showing dermoscopic features that do not definitively indicate melanoma. TBP significantly improves early melanoma detection, enhancing sensitivity and specificity while reducing unnecessary biopsies. However, due to its high cost and limited coverage by the Israeli public health care system, prioritizing patients who would benefit most from TBP is crucial. The compiled list of indications aligns with international recommendations and provides further details within the article.

Identifiants

pubmed: 38616637

Types de publication

English Abstract Journal Article

Langues

heb

Sous-ensembles de citation

IM

Pagination

252-258

Auteurs

Ofer Reiter (O)

Dermatology Division, Rabin Medical Center, Petah Tikva, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv.

Mor Miodovnik (M)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Dermatology Division, Tel Aviv Medical Center, Tel Aviv, Oncology Department, Tel Aviv Medical Center, Tel Aviv.

Emily Avitan-Hersh (E)

Dermatology Department, Rambam Medical Center and Technion Faculty of Medicine, Haifa.

Nadav Astman (N)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Dermatology Division, Sheba Medical Center, Tel Hashomer.

Nir Nathanson (N)

Dermatology Division, Sheba Medical Center, Tel Hashomer.

Ayelet Rishpon (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Dermatology Division, Tel Aviv Medical Center, Tel Aviv.

Aviv Barzilai (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Dermatology Division, Sheba Medical Center, Tel Hashomer, Pathology Department, Sheba Medical Center, Tel Hashomer.

Alon Scope (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Kittner Skin Cancer Screening and Research Institute, Sheba Medical Center, Tel Hashomer.

Classifications MeSH